DraftKings (DKNG) is trading at $19.66, up 1.29% on the session, but the stock is still digesting a wave of analyst downgrades and target cuts from Berenberg, Wells Fargo, JPMorgan, UBS, and Stifel...

DraftKings (DKNG) has taken a clear hit from the sell side over the last two sessions. Berenberg cut the stock from Buy to Hold and reduced its target to $20 from $27.50, citing uncertainty around returns on investment in prediction-markets business and higher customer acquisition costs. Wells Fargo moved from Overweight to Equal Weight and lowered its target to $21 from $30 after the quarterly results and reduced outlook. JPMorgan cut to Neutral with a $21 target, while UBS moved to Neutral and cut its target to $22 from $48, pointing to the reduced outlook and projected prediction-market losses. Stifel also downgraded the shares to Hold and trimmed its target to $21 from $32.

Taken together, those calls matter because they pull the street’s framing back toward execution risk rather than growth optionality. The common thread is not just valuation caution; it is concern that incremental spend is not translating into clean returns.

DKNG was last at $19.66, up 1.29% on the day, with a 24-hour range of $19.01 to $19.88. That leaves the stock above immediate support at $19.15 and the pivot point at $19.52, but still below immediate resistance at $20.02 and stronger resistance at $20.39.

The broader technical picture is still fragile. 03, which fits a short-term distribution setup. 67 is basically in line with spot, but the stock remains below the 20-day and 50-day trend markers, so the bounce has not yet reclaimed trend control.

Source link